Normal liver function is able to take tenofovir in certain cases, such as the presence of hepatitis B virus infection in the organism.
Tenofovir is a new nucleotide reverse transcriptase inhibitor. It is mainly indicated for hepatitis B virus infection as well as HIV and other related antiviral treatments.
Major adverse reactions include generalized weakness, gastrointestinal symptoms such as nausea, vomiting, flatulence and pancreatitis. A small percentage of patients can develop hypophosphatemia, lactic acidosis, dizziness, headache, dyspnea, and hypersensitivity.
Tenofovir has proven efficacy in treating hepatitis B and controlling viral replication, and is the first-line drug used in the treatment of hepatitis B. It is also used in the treatment of hepatitis B in patients with normal liver function.
When liver function is normal, but if age over 30 years old, recent history of hepatocellular carcinoma, etc.; liver histology or non-invasive examination has obvious evidence of fibrosis; the appearance of extra-hepatic manifestations such as hepatitis B virus-associated nephritis, etc.; the above all need antiviral treatment. Tenofovir may be considered at this time.
When liver function is normal, it is recommended that other tests be performed to determine the next step in the dosing regimen. All of the above medications should be used in accordance with your doctor’s instructions.